Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score

BACKGROUND: The established Erlangen Score (ES) for the interpretation of cerebrospinal fluid (CSF) biomarkers in the diagnostics of Alzheimer’s disease (AD) uses markers of amyloidopathy and tauopathy, equally weighted to form an easy-interpretable ordinal scale. However, these biomarkers are not e...

Descripción completa

Detalles Bibliográficos
Autores principales: Utz, Janine, Olm, Pauline, Jablonowski, Johannes, Siegmann, Eva-Maria, Spitzer, Philipp, Lewczuk, Piotr, Kornhuber, Johannes, Maler, Juan Manuel, Oberstein, Timo Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657695/
https://www.ncbi.nlm.nih.gov/pubmed/37742651
http://dx.doi.org/10.3233/JAD-230524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657695/
https://www.ncbi.nlm.nih.gov/pubmed/37742651
http://dx.doi.org/10.3233/JAD-230524

Ejemplares similares